The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

Authors

Khanh Bao Tran, The University of Auckland
Justin J. Lang, Public Health Agency of Canada
Kelly Compton, University of Washington School of Medicine
Rixing Xu, University of Washington School of Medicine
Alistair R. Acheson, University of Washington School of Medicine
Hannah Jacqueline Henrikson, University of Washington School of Medicine
Jonathan M. Kocarnik, University of Washington School of Medicine
Louise Penberthy, University of Washington School of Medicine
Amirali Aali, Mashhad University of Medical Sciences, School of Medicine
Qamar Abbas, Endocrinology and Metabolism Research Institute (TUMS)
Behzad Abbasi, Tehran University of Medical Sciences
Mohsen Abbasi-Kangevari, Tehran University of Medical Sciences
Zeinab Abbasi-Kangevari, Uro-Oncology Research Center
Hedayat Abbastabar, Advanced Diagnostic and Interventional Radiology Research Center
Michael Abdelmasseh, Research Center for Immunodeficiencies
Sherief Abd-Elsalam, Tehran University of Medical Sciences
Ahmed Abdelwahab Abdelwahab, Tehran University of Medical Sciences
Gholamreza Abdoli, Digestive Diseases Research Institute
Hanan Abdulkadir Abdulkadir, Experimental Medicine Research Center
Aidin Abedi, Tehran University of Medical Sciences
Kedir Hussein Abegaz, Tehran University of Medical Sciences
Hassan Abidi, Multiple Sclerosis Research Center
Richard Gyan Aboagye, Tehran University of Medical Sciences
Hassan Abolhassani, Research Center for Immunodeficiencies
Abdorrahim Absalan, School of Medicine
Yonas Derso Abtew, Endocrinology and Metabolism Research Institute (TUMS)
Hiwa Abubaker Ali, Tehran University of Medical Sciences
Eman Abu-Gharbieh, Tehran University of Medical Sciences
Basavaprabhu Achappa, Digestive Oncology Research Center

Publication Name

The Lancet

Abstract

Background: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk–outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings: Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6–28·4) and DALYs by 16·8% (8·8–25·0), with the greatest percentage increase in metabolic risks (34·7% [27·9–42·8] and 33·3% [25·8–42·0]). Interpretation: The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Funding: Bill & Melinda Gates Foundation.

Open Access Status

This publication may be available as open access

Volume

400

Issue

10352

First Page

563

Last Page

591

Funding Number

PN-III-P2-2.1-SOL-2020-2-0351

Funding Sponsor

National Institutes of Health

Share

COinS
 

Link to publisher version (DOI)

http://dx.doi.org/10.1016/S0140-6736(22)01438-6